rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-10-6
|
pubmed:abstractText |
To date, no serologic marker has proven effective as a diagnostic test for head and neck squamous cell carcinoma (HNSCC). Levels of metallopanstimulin (MPS), as measured by a difficult to reproduce radioimmunoassay, are significantly elevated in untreated HNSCC patients. Our objective was to develop a simpler MPS assay.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0194-5998
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
131
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
466-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15467619-Blotting, Western,
pubmed-meshheading:15467619-Carcinoma, Squamous Cell,
pubmed-meshheading:15467619-Electrophoresis, Gel, Two-Dimensional,
pubmed-meshheading:15467619-Head and Neck Neoplasms,
pubmed-meshheading:15467619-Humans,
pubmed-meshheading:15467619-Metalloproteins,
pubmed-meshheading:15467619-Nuclear Proteins,
pubmed-meshheading:15467619-Precipitin Tests,
pubmed-meshheading:15467619-RNA-Binding Proteins,
pubmed-meshheading:15467619-Ribosomal Proteins,
pubmed-meshheading:15467619-Tumor Markers, Biological
|
pubmed:year |
2004
|
pubmed:articleTitle |
A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin.
|
pubmed:affiliation |
Division of Otolaryngology, The Milton S. Hershey Medical Center, Penn State University College of Medicine, Hershey, PA 17033-0850, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|